Nome Químico: (E)-3-(2-(((4-(N'-((Hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid
Sorrisos: O=C(O)CCN(C1=NC=CC=C1)C(C2=CC=C3N(C)C(CN(C4=CC=C(/C(N)=N\C(OCCCCCC)=O)C=C4)N=O)=NC3=C2)=O
Inchi: InChI=1S/C25H24N8O4/c1-31-20-10-7-17(25(36)32(13-11-23(34)35)21-4-2-3-12-28-21)14-19(20)29-22(31)15-33(30-37)18-8-5-16(6-9-18)24(26)27/h2-10,12,14H,11,13,15H2,1H3,(H3,26,27)(H,34,35)
Novel method for separation and quantification of potential impurities by RP-HPLC from KSM stage to API stage of dabigatran mesylate
By Jhansi, T. Naga; Nagaraju, R.; Kumar, D. Jaya Deep; Rao, G. Nageswara
From International Journal of Pharmaceutical Sciences and Research (2021), 12(3), 1762-1779
Development and Validation of RP-UPLC Method for the Determination of Process and Degradant Impurities Present in Dabigatran Etexilate Mesylate Capsules Using High Strength Silica-T3 Sorbent Column
By Mantena, Bhaskara P. V.; Rao, Sumathi V.; Suryakala, D.; Ramakrishna, K.; Srikanth Reddy, R.
From Analytical Chemistry Letters (2016), 6(5), 595-611
Determination of dabigatran etexilate mesylate by HPLC
By Jia, Ling-xiao; Tang, Lei; Zhang, Shu-ting; Song, Rui-zhi; Gao, Zhan-wen
From Shipin Yu Yaopin (2015), 17(3), 195-197